Treasury yield is hovering just above a six-week low around 4.50% as investors continue to digest Wednesday’s monetary policy update from the Federal Reserve. The U.S. central bank left interest rates ...
Goldman Sachs is telling investors to take a breath. Peter Oppenheimer, the bank’s chief global equity strategist, has told investors today that markets aren’t crashing—just cooling. “In our view, ...
This particularly applies to tech giants and popular consumer-facing stocks. What if you'd invested in Goldman Sachs (GS) ten years ago? It may not have been easy to hold on to GS for all that ...
Moderna (MRNA) stock falls as Goldman Sachs downgrades the COVID-19 vaccine maker to Neutral from Buy, citing a lack of ...
We recently compiled a list of the Top 10 AI Stocks Dominating Wall Street. In this article, we are going to take a look at ...
Hosted on MSN9d
Goldman Sachs recommends investing in these two sectors as the global population agesIts shares were listed on the Nasdaq for the public to trade in 2024. Brightspring stock has more than doubled over the ...
Hedge funds were already waiting to see if a U.S.-fostered, home-grown artificial intelligence boom would continue as China's ...
Goldman Sachs analyst Michele Della Vigna maintained a Buy rating on Shell (UK) (SHEL – Research Report) today. The company’s shares opened ...
Goldman Sachs has initiated coverage of Vera Therapeutics (NASDAQ:VERA) with a buy rating, citing the potential of its drug candidate atacicept and a recent pullback in the stock. The investment bank ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback